UCT-01-097
- Generic Name
- UCT-01-097
First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors
Phase 1
Terminated
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- 1200 Pharma, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT04761601
- Locations
- 🇺🇸
Torrance Memorial, Torrance, California, United States
🇺🇸Mary Crowley Cancer Research, Dallas, Texas, United States
🇺🇸Winship Institute of Emory University, Atlanta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath